About
Part 2: RNA fusion detection

Originally presented at ESMO 2022

Clinical validation of novel RNA fusion detection for NSCLC with SOPHiA DDM™ Dx RNAtarget Oncology Solution​
Prof. Alexander Harlé, PhD

Enabling clinical workflows in Trusted Research Environments ​
Gaetano Bonifacio, PhD
on-demand webinar
Agenda
  • Clinical validation of novel RNA fusion detection for NSCLC with SOPHiA DDM tm Dx RNAtarget Oncology Solution​
  • Enabling clinical workflows in Trusted Research Environments ​
Presenters
1571226-1556610220
SOPHiA GENETICS
1665087056-e33b55bcf2dd855e
Prof. Alexander Harlé, PhD
Biologist/Professor of liquid biopsy and tumor heterogeneity group, Institut de Cancérologie de Lorraine-Alexis Vautrin ​
1665087299-a53c62ae2c53cab5
Gaetano Bonifacio, PhD
Industry Advisor-Healthcare, Microsoft​
Register To Watch Recording
Full name*
Email Address*
Institution/Company*
City*
Country *
✓ By checking this box, I agree to receive information from SOPHiA GENETICS about corporate news and/or promotional communication. You will be able to unsubscribe by using the link integrated with the communication at any time.
✓ Privacy Policy: By checking this box, I declare that I have read and accepted in full the SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. For more information relating to our privacy policy, visit: https://www.sophiagenetics.com/privacy-policy*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker